Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
基本信息
- 批准号:9904675
- 负责人:
- 金额:$ 137.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Action ResearchAcuteAdvanced DevelopmentAffectAnimal ExperimentsAnimal ModelAnimalsAreaAtmosphereAttenuatedAwarenessBiologicalBiological MarkersCardiovascular DiseasesCause of DeathChemical ExposureChemicalsChemistryChronicCommunitiesCommunity OutreachComplementCost MeasuresCritical PathwaysDataDecision MakingDetectionDevelopmentDevicesDiabetes MellitusDiseaseDisease PathwayEcologyEducation and OutreachEnsureEnvironmentEnvironmental ExposureEpidemicEpidemiologyEtiologyEvaluationExposure toFatty LiverFoundationsFutureGoalsHazardous ChemicalsHazardous SubstancesHazardous Waste SitesHealthHeart DiseasesHumanIncidenceIndustrializationInjuryInvestigationKnowledgeLiver diseasesMass Spectrum AnalysisMeasuresMedicalMetabolismMethodsMolecularMonitorNon-Insulin-Dependent Diabetes MellitusNutritionalNutritional statusObesityPathway interactionsPopulationPostdoctoral FellowPredispositionPrevalencePrivate SectorPublic HealthPublic SectorResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResourcesRiskSamplingScienceSeveritiesSiteSuperfundTechniquesTechnologyTestingTherapeutic InterventionTimeTissue SampleToxic effectToxicity TestsToxicologyTrainingTraining ProgramsTranslational ResearchUniversitiesValidationWorkanimal tissuebasebiobankcardiometabolismcomputer codedata archivedata managementdata sharingeducation resourcesexperienceexposed human populationgraduate studenthuman population studyhuman tissueinnovationinterestmembermetabolomicsmultidisciplinarynew technologynovel markerobesity developmentoutreach programpollutantprogramsremediationrepositoryresilienceresponsesuperfund chemicalsuperfund sitetooltranslational medicinevolatile organic compound
项目摘要
PROJECT SUMMARY (Overall)
This proposal is to establish a Superfund Center at the University of Louisville. This Center will support research
on the cardiometabolic effects of volatile organic chemicals (VOCs) that are of high relevance to the Superfund
Program. Center investigators will conduct mode-of-action research to unravel critical pathways of toxicity and
to identify toxicological end-points (cardiometabolic changes) of chemicals (VOCs) found at Superfund and
related sites. Using high throughput metabolomic and mass spectrometry approaches, animal experiments and
human population studies, Center investigations will aid in the discovery and validation of novel biomarkers of
both exposure and cardiometabolic injury that would lay the foundation for future remediation strategies. These
studies will employ state-of-the-art tools to develop pollutant atmospheres for animal exposure and to measure
unique and sensitive biological endpoints reflective of cardiometabolic injury. In addition, work supported by the
Center will lead to the development of new methods and devices for quantifying atmospheric levels of VOCs that
will employ advanced technologies and offer precise, but low-cost measurements of hazardous waste sites. The
major objectives of the Center are to conduct state-of-the-art research on the cardiometabolic toxicity of VOCs
and to determine how they affect cardiometabolic disease (CMD) prevalence and severity in exposed
populations. These studies will be complemented by mode-of-action mechanistic studies in animals to identify
the molecular and cellular mechanisms that contribute to VOC toxicity. Center investigators will also identify
specific conditions such as nutritional status and obesity and increase susceptibility to VOC toxicity and test
therapeutic interventions that can attenuate acute and chronic cardiometabolic effects of VOC exposures. The
findings of these studies will contribute to both the discovery and the validation of sensitive and robust biomarkers
that could be used to assess the extent of exposure, metabolism and toxicity. Center investigators will create
new technologies for detecting VOCs at low environmental levels to enable future exposure assessment
activities. Senior Center members will educate and train junior investigators, graduate students and post-doctoral
Fellows in the field of environmental science, and promote relevant community awareness and participation to
enhance mutual bidirectional understanding of exposure risk and the health effects of exposure. The findings
and discoveries of the Center will be transferred to affected communities, end users in public and private sectors,
and other stakeholders. For future use and analysis, all samples of human and animal tissues and all data
collected during Center investigations will be stored in a computer-coded biorepository. Collectively, Center
activities will lead to rigorous evaluation and better understanding of the effects of these hazardous chemicals
on obesity, diabetes and cardiovascular disease.
项目摘要(总体)
该建议是在路易斯维尔大学建立超级基金中心。该中心将支持研究
关于与超级基金高相关的挥发性有机化学物质(VOC)的心脏代谢作用
程序。中心研究人员将进行行动方式研究,以阐明毒性的关键途径和
确定在超级基金和
相关站点。使用高通量代谢组和质谱法,动物实验和
人口研究,中心调查将有助于发现和验证新型生物标志物
暴露和心脏代谢损伤都将为将来的补救策略奠定基础。这些
研究将采用最先进的工具来开发动物暴露的污染物气氛并测量
独特而敏感的生物学终点反映了心脏代谢损伤。此外,由
中心将导致开发新方法和设备,以量化大气水平的VOC水平
将采用先进的技术,并提供精确但低成本的危险废物站点的测量。这
该中心的主要目标是就VOC的心脏代谢毒性进行最先进的研究
并确定它们如何影响裸露的心脏代谢疾病(CMD)患病率和严重程度
人群。这些研究将通过动物的行动方式进行补充,以识别
有助于VOC毒性的分子和细胞机制。中心调查人员还将确定
营养状况和肥胖等特定条件,并增加对VOC毒性和测试的敏感性
可以减轻VOC暴露的急性和慢性心脏代谢作用的治疗干预措施。这
这些研究的发现将有助于发现敏感和健壮的生物标志物的发现和验证
可以用来评估暴露,代谢和毒性的程度。中心调查人员将创建
用于检测低环境水平的VOC的新技术,以实现未来的曝光评估
活动。高级中心成员将教育和培训初级调查员,研究生和博士后
环境科学领域的研究员,并促进相关的社区意识和参与
增强对暴露风险和暴露健康影响的相互双向理解。发现
该中心的发现将被转移到受影响的社区,公共和私营部门的最终用户,
和其他利益相关者。供将来的使用和分析,所有人类和动物组织的样本以及所有数据
中心调查期间收集的将存储在计算机编码的生物座位中。集体,中心
活动将导致严格的评估,并更好地理解这些危险化学物质的影响
关于肥胖,糖尿病和心血管疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjay Srivastava其他文献
Sanjay Srivastava的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjay Srivastava', 18)}}的其他基金
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
9917380 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10533743 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10317034 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10082463 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
项目2——VOCs心脏代谢毒性的分子和细胞机制
- 批准号:
10693804 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
10354688 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
KC Donnelly Externship–Promotion of Translational/Transdisciplinary Efforts in Graduate & Post-Doctoral Research
KC Donnelly 实习 — 促进研究生的转化/跨学科努力
- 批准号:
10382018 - 财政年份:2017
- 资助金额:
$ 137.89万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
PTPRD phosphatase inhibitors for stimulant use disorders
PTPRD 磷酸酶抑制剂治疗兴奋剂使用障碍
- 批准号:
10653070 - 财政年份:2022
- 资助金额:
$ 137.89万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10401460 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10194368 - 财政年份:2020
- 资助金额:
$ 137.89万 - 项目类别:
Targeting the menin-MLL1 complex for new therapeutics
靶向 menin-MLL1 复合物的新疗法
- 批准号:
10379367 - 财政年份:2018
- 资助金额:
$ 137.89万 - 项目类别:
Project 3 - Development and investigation of murine models of channelopathy-associated epilepsy
项目 3 - 通道病相关癫痫小鼠模型的开发和研究
- 批准号:
10477456 - 财政年份:2018
- 资助金额:
$ 137.89万 - 项目类别: